Krsnaa Diagnostics expands Himachal CT Scan partnership to 34 sites

2 min read     Updated on 23 Jul 2026, 10:04 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Krsnaa Diagnostics Limited has signed a PPP agreement with the Himachal Pradesh government to operate CT Scan facilities at 34 health institutions, up from 12 previously. The seven-year deal, extendable by three years, operates on a majority cash basis, enhancing revenue visibility. This marks one of the company's largest government partnerships, strengthening its regional footprint.

powered bylight_fuzz_icon
46370053

*this image is generated using AI for illustrative purposes only.

Krsnaa Diagnostics has significantly expanded its diagnostic footprint in Himachal Pradesh by securing a Public Private Partnership (PPP) Agreement with the Director Health Services, Health & Family Welfare Department, Government of Himachal Pradesh. The deal involves setting up, operating, managing, maintaining, and reporting CT Scan Diagnostic Facilities at 34 Government Health Institutions across the state, replacing an earlier arrangement that covered only 12 institutions. This expansion underscores the company’s growing dominance in public-sector healthcare partnerships and reinforces its position as a preferred service provider for diagnostics in the region.

The agreement was disclosed on July 23, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The project will be implemented on a PPP basis for an initial period of seven years, extendable by a further three years on mutually agreed terms. Notably, the contract operates on a majority cash basis, providing greater revenue visibility compared to purely reimbursement-based models.

Key Contract Details

Particulars Details
Awarding Entity Director Health Services, Health & Family Welfare Department, Government of Himachal Pradesh
Scope Setting up and operating CT Scan Centres at 34 Government Health Institutions
Model Public Private Partnership (PPP) on a majority cash basis
Duration Initial period of seven years, extendable by three years
Previous Scope 12 Government Health Institutions
Contract Value Cannot be estimated as it is a new project

The expansion from 12 to 34 institutions represents a substantial increase in operational scale for Krsnaa Diagnostics . The company described this as one of the largest government partnerships undertaken for CT Scan diagnostic services. The move demonstrates the company's ability to successfully renew and scale up existing contracts, aligning with its strategic focus on healthcare excellence and expanded geographic reach within Himachal Pradesh.

Strategic Implications

The shift to a majority cash basis is a material development for the company’s cash flow dynamics in the state. Unlike traditional government contracts that may rely heavily on delayed reimbursements, a cash-based model suggests immediate or near-immediate revenue realization from end-users, potentially improving working capital efficiency. The extension option of three years provides long-term stability, allowing for better amortization of capital expenditures required for setting up the new facilities.

This partnership consolidates Krsnaa Diagnostics' presence in Himachal Pradesh, a key market for rural and semi-urban healthcare expansion. By scaling up from 12 to 34 locations, the company is likely to achieve economies of scale in operations and maintenance, further strengthening its competitive moat against private players in the region. The absence of promoter interest or related-party transactions in this award ensures the deal is conducted at arm's length, reflecting genuine market demand for the company's services.

Historical Stock Returns for Krsnaa Diagnostics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.98%-2.30%+0.28%-24.47%-37.22%-45.65%

How will the shift to a majority cash-based revenue model impact Krsnaa Diagnostics' working capital efficiency and overall liquidity compared to its previous reimbursement-heavy contracts?

What are the estimated capital expenditures required to set up CT Scan facilities at the additional 22 institutions, and how will this affect the company's near-term free cash flow?

Given the expansion in Himachal Pradesh, is Krsnaa Diagnostics likely to pursue similar large-scale PPP agreements in other high-potential rural or semi-urban states in India?

Krsnaa Diagnostics appoints three independent directors

1 min read     Updated on 07 Jul 2026, 02:25 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Krsnaa Diagnostics Limited received shareholder approval to re-appoint Mr. Chetan Desai and appoint Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Independent Directors. Shareholders also approved remuneration by way of commission to Independent Directors. The resolutions were passed through a remote e-voting process conducted by NSDL.

powered bylight_fuzz_icon
44902647

*this image is generated using AI for illustrative purposes only.

Krsnaa Diagnostics Limited has received shareholder approval to re-appoint Mr. Chetan Desai as a Non-Executive Independent Director for a second term and appoint two new Independent Directors, Mr. Raju Venkatraman and Ms. Lilian Jessie Paul. The resolutions were passed via a remote e-voting process that concluded on July 04, 2026, with the requisite majority required under the Companies Act, 2013.

The postal ballot notice, dated April 17, 2026, sought approval for four special resolutions. In addition to the director appointments, shareholders approved the payment of remuneration by way of commission to the Independent Directors of the company. Mr. Dinesh Shivnarayan Birla, Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, served as the Scrutinizer for the e-voting process and submitted the report on July 06, 2026.

Voting Results Summary

The remote e-voting was conducted by National Securities Depository Limited (NSDL). A total of 18,652,677 votes were polled across all resolutions, representing 57.5014% of the total outstanding shares. The Promoter and Promoter Group cast 8,795,605 votes in favour of all resolutions. Public Institutions and Non-Institutions also participated, with varying levels of support recorded for each resolution.

Resolution Breakdown

Resolution Votes For Votes Against % For % Against
Re-appointment of Mr. Chetan Desai 17,345,454 1,307,223 92.9918 7.0082
Appointment of Mr. Raju Venkatraman 18,642,092 10,585 99.9433 0.0567
Appointment of Ms. Lilian Jessie Paul 18,642,027 10,650 99.9429 0.0571
Commission to Independent Directors 18,620,251 32,426 99.8262 0.1738

Procedural Details

The e-voting facility was open from June 05, 2026, to July 04, 2026. Equity shareholders holding shares on the cut-off date of May 29, 2026, were entitled to vote. The company published advertisements regarding the e-voting facility in the Financial Express and Loksatta newspapers on June 04, 2026. The detailed Scrutinizer's Report and voting results have been made available on the company's website.

Historical Stock Returns for Krsnaa Diagnostics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.98%-2.30%+0.28%-24.47%-37.22%-45.65%

How will the expertise of the newly appointed independent directors influence Krsnaa Diagnostics' strategic expansion plans?

What specific governance changes or initiatives can be expected under Mr. Chetan Desai's second term?

How will the approved commission structure for independent directors impact the company's operational costs?

More News on Krsnaa Diagnostics

1 Year Returns:-37.22%